You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
21 September 2026 - Biopharmaceutical company Insmed Incorporated (Nasdaq: INSM) disclosed on Monday that the US Food and Drug Administration has accepted its supplemental New Drug Application for ARIKAYCE (amikacin liposome inhalation suspension) fo...
21 September 2026 - Biopharmaceutical company Precigen Inc (Nasdaq: PGEN) disclosed on Monday that it has received US Food and Drug Administration platform technology designation for its AdenoVerse immunotherapeutic platform, which underpins its firs...
21 September 2026 - British-Swedish biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) and Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) announced on Monday that Enhertu (trastuzumab deruxtecan) has been recommend...
21 September 2026 - Biotherapeutics company PureTech Health plc (LSE: PRTC) announced on Monday that it has completed a successful End-of-Phase 1 meeting with the U.S. Food and Drug Administration and received Fast Track designation for LYT-200 in co...
21 September 2026 - Oncology company Coiled Therapeutics plc (AIM: COIL) (OTCQB: COTXF) declared on Monday that it has completed enrollment across two cohorts evaluating its new lipid-based softgel formulation of AO-252, enrolling three patients each...
18 September 2026 - Otsuka ICU Medical LLC, a manufacturer of IV solutions for healthcare providers, announced on Thursday that it is issuing a voluntary recall for one lot of 0.9% SODIUM CHLORIDE Injection, USP, 100mL single pack to the user level d...
17 September 2026 - German pharmaceutical and life sciences company Bayer AG (ETR:BAYN) (OTC:BAYRY) said on Thursday that the US Food and Drug Administration (FDA) has approved Kerendia (finerenone) to reduce urinary albumin-to-creatinine ratio in ad...